Voices
Gaurav Dixit: CAR T-Cell Therapy for Relapsed and Refractory Blood Cancers
Gaurav Dixit/X

Gaurav Dixit: CAR T-Cell Therapy for Relapsed and Refractory Blood Cancers

Gaurav Dixit, Head , Hematoncology and BMT at Artemis Hospitals, shared on X:

“CAR T-cell therapy uses specially modified T cells to target certain blood cancers. It may be considered in selected relapsed or refractory cases after detailed specialist evaluation.

Location: Gurugram  Hisar

Call – 7042555674.”

Gaurav Dixit

You might be interested in: CAR T-Cell Therapy: A New Frontier in Cancer Immunotherapy

Gaurav Dixit: CAR T-Cell Therapy for Relapsed and Refractory Blood Cancers

blood cancer cancer CAR T-cell therapy Gaurav Dixit OncoDaily Oncology T cells